Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem M...

por Jiang, Jianwei, Zou, Xiaowen, Liu, Yuke, Liu, Xiao, Dong, Kai, Yao, Xiaoqing, Feng, Zhiqiang, Chen, Xiaoguang, Sheng, Li, Li, Yan
Publicado 2021

Metabolism of IMM-H004 and Its Pharmacokinetic-Pharmacodynamic Analysis in Cerebral Ischemia/Reperfusion Injured Rats

por Zhang, Ziqian, Liu, Dandan, Jiang, Jianwei, Song, Xiuyun, Zou, Xiaowen, Chu, Shifeng, Xie, Kebo, Dai, Jungui, Chen, Naihong, Sheng, Li, Li, Yan
Publicado 2019

Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug

por Wang, Yuchen, Liu, Xiao, Zou, Xiaowen, Wang, Shuting, Luo, Lijun, Liu, Yuke, Dong, Kai, Yao, Xiaoqing, Li, Yan, Chen, Xiaoguang, Sheng, Li
Publicado 2021

PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway

por Lin, Youcheng, Yang, Zhao, Xu, Abai, Dong, Pei, Huang, Yi, Liu, Huan, Li, Feida, Wang, Haifeng, Xu, Qian, Wang, Yongqiang, Sun, Da, Zou, Yong, Zou, Xiaowen, Wang, Yu, Zhang, Duo, Liu, Hongjie, Wu, Xun, Zhang, Meng, Fu, Yu, Cai, Zhiming, Liu, Chunxiao, Wu, Song
Publicado 2015